Abstract:537 Background: Effective communication is essential to build trust and improve patient understanding of cancer diagnosis and treatment. Little is known about patient comprehension of provider explanations and whether better communication influences adherence to recommended treatment especially in breast cancer (BC) which may require years of adjuvant treatment. Methods: Between 7/2023-8/2023, active patients and survivors were recruited from Breastcancer.org and consented to participate in an anonymous online survey in English or Spanish. Eligibility included: US resident, age ≥18, and diagnosed with BC within the past 10 years. Survey assessed patient-reported overall communication, side effect communication, and treatment adherence. Multivariate analysis (MVA) assessed relationship of patient-reported understanding and treatment adherence after controlling for gender, age, stage, race, ethnicity, and education. Results: Of 1266 screened, 997 met eligibility and participated. 98.2% identified as women, 81.2% White, 4.8% Black, and 4.2% Hispanic. Median age was 62 (interquartile range IQR 53-69) and median time since diagnosis 2.1 years (IQR 1-5.1). 6.5% had metastatic disease. 77.3% had a college degree. 93.4% participants reported their doctors “usually” or “always” explained things in a way they could understand. On MVA, there was a trend for minoritized groups (Black, Hispanic, Indigenous patients) to report their doctors were less likely to explain things well (OR 0.57, 95%CI 0.30-1.06, p=0.08) but there were no significant differences. Most felt their doctors “definitely” (45.8%) or “to some extent” (10.3%) explained possible short-term side effects. One-third (35.2%) stated their doctors explained “to some extent” and that they also did their own research to fully understand short-term side effects; 6.1% stated that their own research was the only thing that helped them understand as their doctors did not explain. Less than one-third (27.9%) felt their doctors “definitely” explained possible long-term side effects. 7.7% participants took less medication that their doctors prescribed due to treatment side effects, 15.1% stopped taking a medication or treatment altogether. Patients who reported that their doctors were “sometimes” or “never” understandable were more likely to reduce or stop their treatment (44.4% vs 21.3%, p<0.001). This held true on MVA: patients reporting poor communication were less likely to adhere to recommended treatment (OR 0.36, 95%CI 0.21-0.62, p<0.001). Conclusions: Surveyed patients with BC report good provider communication skills overall but note that side effect profiles are not always well-explained, especially for long-term side effects. More than 1 in 5 did not follow some aspect of BC treatment as recommended, and those who reported poor communication with their providers were 64% less likely to be adherent to recommended care.

Therapeutic adherence of patients with breast and prostate cancers

Adherence and quality of life in women with breast cancer being treated with oral hormone therapy

Adverse Drug Reactions and Predictors of Medication Adherence in Patients with Prostate Cancer

A study of compliance of adjuvant endocrine therapy in breast cancer patients

Adherence to oral anticancer hormonal therapy in breast cancer patients and its relationship with treatment satisfaction: an important insight from a developing country

Patient-reported provider communication skills and adherence to recommended treatment in breast cancer.

Factors Influencing Adherence to Adjuvant Endocrine Therapy After Breast Cancer Surgery

Adherence to antiretroviral therapy and factors associated with non-adherence: a cohort study at two referral services in Brazil

Adherence Status to Adjuvant Endocrine Therapy in Chinese Women with Early Breast Cancer and Its Influencing Factors: A Cross‐sectional Survey

Nonadherence to medications for chronic conditions and risk of nonadherence to androgen receptor signaling inhibitors (ARSIs) in patients with prostate cancer.

Assessment of endocrine therapy adherence in a nurse-led cancer survivorship clinic: Results from the Linking You to Support and Advice (LYSA) trial.

Adherence to adjuvant hormonal therapy in breast cancer patients

Adherence to Endocrine Therapy in Patients with Hormone Receptor-Positive Early-Stage Breast Cancer: a Retrospective Study.

The Influence of Pharmaceutical Care in Patients with Breast Cancer Receiving Adjuvant Endocrine Therapy

Factors influencing the first and the fifth years adherence to adjuvant endocrine therapy in breast cancer patients in a low income country

Exploring the factors influencing adherence to oral anticancer drugs in patients with digestive cancer: a qualitative study

The Patient's Voice: Adherence, Symptoms, and Distress Related to Adjuvant Endocrine Therapy After Breast Cancer

THERAPEUTIC ADHERENCE IN A POPULATION OF PATIENTS TREATED FOR SCHIZOPHRENIA AT THE HOSPITAL FOR MENTAL HEALTH AND PSYCHIATRIC DISORDERS IN TANGIER

Patterns and determinants of adherence to resistance and endurance training during cancer treatment in the Phys-Can RCT

(Pm-08) Physical Activity In Patients With Prostate Cancer: The Impact On Quality Of Life And Sexual Life

Factors influencing five-year adherence to adjuvant endocrine therapy in breast cancer patients: A systematic review